Literature DB >> 14986159

Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.

R Colodner1, W Rock, B Chazan, N Keller, N Guy, W Sakran, R Raz.   

Abstract

Although the risk factors for acquiring infection by extended-spectrum beta-lactamase (ESBL)-producing bacteria have been investigated in hospitalized patients, such risk factors have not been defined in the community setting. In this study, clinical data from a total of 311 nonhospitalized patients with community-acquired urinary tract infection (128 with ESBL-positive strains and 183 with ESBL-negative strains) were obtained. According to a multivariate analysis, the following were identified as independent risk factors: previous hospitalization in the past 3 months (OR=8.95, 95%CI, 3.77-21.25), antibiotic treatment in the past 3 months (OR=3.23, 95%CI, 1.76-5.91), age over 60 years (OR=2.65, 95%CI, 1.45-4.83), diabetes (OR=2.57, 95%CI, 1.20-5.51), male gender (OR=2.47, 95%CI, 1.22-5.01), Klebsiella pneumoniae infection (OR=2.31, 95%CI, 1.17-4.54), previous use of third-generation cephalosporins (P=0.014, OR=15.8, 95%CI, 1.7-143), previous use of second-generation cephalosporins (P<0.0001, OR=10.1, 95%CI, 4.2-24), previous use of quinolones (P=0.001, OR=4.1, 95%CI, 1.8-9.0), and previous use of penicillin (P=0.003, OR=4.0, 95%CI, 1.6-9.0).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14986159     DOI: 10.1007/s10096-003-1084-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  Antimicrobial susceptibility of community-acquired uropathogens in northern Israel.

Authors:  R Colodner; Y Keness; B Chazan; R Raz
Journal:  Int J Antimicrob Agents       Date:  2001-08       Impact factor: 5.283

Review 2.  Successful interventions for gram-negative resistance to extended-spectrum beta-lactam antiobiotics.

Authors:  L B Rice
Journal:  Pharmacotherapy       Date:  1999-08       Impact factor: 4.705

3.  Broad-spectrum, transmissible beta-lactamases.

Authors:  G A Jacoby; A A Medeiros; T F O'Brien; M E Pinto; H Jiang
Journal:  N Engl J Med       Date:  1988-09-15       Impact factor: 91.245

4.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

5.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel.

Authors:  Abraham Borer; Jacob Gilad; Galia Menashe; Nechama Peled; Klaris Riesenberg; Francisc Schlaeffer
Journal:  Med Sci Monit       Date:  2002-01

6.  Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel.

Authors:  R Raz; N Okev; Y Kennes; A Gilboa; I Lavi; N Bisharat
Journal:  Isr Med Assoc J       Date:  2000-06       Impact factor: 0.892

7.  Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

Authors:  D L Paterson; L Mulazimoglu; J M Casellas; W C Ko; H Goossens; A Von Gottberg; S Mohapatra; G M Trenholme; K P Klugman; J G McCormack; V L Yu
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

8.  Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain.

Authors:  S P Barrett; M A Savage; M P Rebec; A Guyot; N Andrews; S B Shrimpton
Journal:  J Antimicrob Chemother       Date:  1999-09       Impact factor: 5.790

9.  Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

Authors:  J Wiener; J P Quinn; P A Bradford; R V Goering; C Nathan; K Bush; R A Weinstein
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

10.  Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.

Authors:  J P Quinn; D Miyashiro; D Sahm; R Flamm; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

View more
  93 in total

1.  Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria.

Authors:  Reid R Hoshide; Heath Chung; Jinichi Tokeshi
Journal:  Hawaii Med J       Date:  2011-09

2.  Frequency of extended-spectrum β-lactamase (ESBL)-producing Gram-negative bacilli in a 200-bed multi-specialty hospital in Vellore district, Tamil Nadu, India.

Authors:  S Sankar; H Narayanan; S Kuppanan; B Nandagopal
Journal:  Infection       Date:  2012-04-25       Impact factor: 3.553

3.  Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.

Authors:  Corinne Arpin; Véronique Dubois; Jeanne Maugein; Jacqueline Jullin; Brigitte Dutilh; Jean-Philippe Brochet; Gilberte Larribet; Isabelle Fischer; Claudine Quentin
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Canadian practice guidelines for surgical intra-abdominal infections.

Authors:  Anthony W Chow; Gerald A Evans; Avery B Nathens; Chad G Ball; Glen Hansen; Godfrey Km Harding; Andrew W Kirkpatrick; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

5.  Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis.

Authors:  M-A Vibet; J Roux; E Montassier; S Corvec; M-E Juvin; C Ngohou; D Lepelletier; E Batard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-24       Impact factor: 3.267

6.  Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals.

Authors:  C M Lonchel; P Melin; J Gangoué-Piéboji; M-C O Assoumou; R Boreux; P De Mol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-11       Impact factor: 3.267

Review 7.  The continuing challenge of ESBLs.

Authors:  Federico Perez; Andrea Endimiani; Kristine M Hujer; Robert A Bonomo
Journal:  Curr Opin Pharmacol       Date:  2007-09-17       Impact factor: 5.547

8.  Screening of clinical, food, water and animal isolates of Escherichia coli for the presence of blaCTX-M extended spectrum beta-lactamase (ESBL) antibiotic resistance gene loci.

Authors:  John E Moore; Miyuki Watabe; B Cherie Millar; Anne Loughrey; Mark McCalmont; Colin E Goldsmith; J C Neville Heaney; Tom Buckley; Claire Egan; David A McDowell; M Ann S McMahon; James S G Dooley; Jiru Xu; Paul J Rooney
Journal:  Ulster Med J       Date:  2010-05

9.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae in a Malian orphanage.

Authors:  Didier Tandé; Nelle Jallot; Flabou Bougoudogo; Tracey Montagnon; Stéphanie Gouriou; Jacques Sizun
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

10.  Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization.

Authors:  Sylvain Brisse; Cindy Fevre; Virginie Passet; Sylvie Issenhuth-Jeanjean; Régis Tournebize; Laure Diancourt; Patrick Grimont
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.